Breast Cancer Research Restored Mei's Quality of Life
Mei has been living with breast cancer since 1996 and has tried nearly a dozen different cancer medications—each with difficult side effects. That changed when she began taking a new drug called elacestrant, approved by the FDA in 2023 after clinical trials at Duke howed its effectiveness. For the first time in decades, Mei is experiencing real progress—without the side effects.
Elacestrant was discovered in the lab of Dr. Donald McDonnell, a cancer pharmacology professor at Duke University. Its path from lab bench to lifesaving treatment is a powerful example of what’s possible through long-term federal investment in biomedical research—and the vital role universities play in turning discoveries into real-world impact.
Hear Mei’s story. Discover the science. And see how Duke research saves lives.
#breastcancer #breastcancerawareness #research
Find out more about Dr. McDonnell's path to discovering Elacestrant could help breast cancer patients:
https://today.duke.edu/2025/04/how-du...
@DukeHealth @dukemedschool
𝐀𝐛𝐨𝐮𝐭 𝐃𝐮𝐤𝐞 𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲
Established in 1924 in Durham, North Carolina, Duke University is one of the world’s leading institutions for education, research, and patient care.
Subscribe ➡️ / @dukeuniversity
Home: duke.edu
News: today.duke.edu
X (Formerly Twitter): @DukeU
Instagram: @dukeuniversity
Facebook: @dukeuniv
LinkedIn: @DukeUniversity
MB0160T83HSDUEK